Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Thoracic Oncology Topic Center

Featured Article

News
Checkpoint Inhibitors To Play Major Role in Treatment of NSCLC
12/15/2017
A recent study in The Ochsner Journal examined the role of checkpoint inhibition in non–small cell lung cancer treatment. 
A recent study in The Ochsner Journal examined the role of checkpoint inhibition in non–small cell lung cancer treatment. 
A recent study in The Ochsner...
12/15/2017
First Report Managed Care
News
Hospitalization for Resection Cost-Effective in High-Risk Lung Cancer Patients
12/01/2017
A recent study sought to understand the impact of costs incurred through hospitalization after resection among lung cancer patients.
A recent study sought to understand the impact of costs incurred through hospitalization after resection among lung cancer patients.
A recent study sought to...
12/01/2017
First Report Managed Care
News
Recent Research Reports New Treatment Options for NSCLC
11/21/2017
Recent research, reported in The New England Journal of Medicine, showed that Tagrisso improved outcomes among non-small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor.
Recent research, reported in The New England Journal of Medicine, showed that Tagrisso improved outcomes among non-small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor.
Recent research, reported in The...
11/21/2017
First Report Managed Care
News
FDA Authorizes IMPACT Test to Speed Precision Oncology Treatment
11/17/2017
The FDA has authorized an in vitro diagnostic test that can rapidly identify cancer mutations and allow oncologists to determine treatment options more quickly.
The FDA has authorized an in vitro diagnostic test that can rapidly identify cancer mutations and allow oncologists to determine treatment options more quickly.
The FDA has authorized an in...
11/17/2017
First Report Managed Care
News
Additional NSCLC Treatments Needed to Reduce Post-Progression Costs
11/16/2017
A recent poster at AMCP Nexus 2017 found that costs during TKI treatment for Non-small cell lung cancer were similar to costs after progression, due to high hospital utilization.
A recent poster at AMCP Nexus 2017 found that costs during TKI treatment for Non-small cell lung cancer were similar to costs after progression, due to high hospital utilization.
A recent poster at AMCP Nexus...
11/16/2017
First Report Managed Care

Newsfeed

Newsfeed
CMS Proposes Medicare Advantage and Part D Changes to Maximize Competition and Coverage
01/31/2019
The Centers for Medicare & Medicaid Services released Part II of proposed changes to Medicare Advantage and Part D that will increase plan choices, add new benefits, and address the opioid crisis.
The Centers for Medicare & Medicaid Services released Part II of proposed changes to Medicare Advantage and Part D that will increase plan choices, add new benefits, and address the opioid crisis.
The Centers for Medicare &...
01/31/2019
First Report Managed Care
Newsfeed
Washington Offers Winner-Take-All Deal in HCV Treatment Subscription Model
01/30/2019
Officials in Washington take a Netflix model of subscription for purchasing hepatitis C drugs further by planning to sign a winner-take-all deal with a pharmaceutical company.
Officials in Washington take a Netflix model of subscription for purchasing hepatitis C drugs further by planning to sign a winner-take-all deal with a pharmaceutical company.
Officials in Washington take a...
01/30/2019
First Report Managed Care
Newsfeed
Cost Savings for Patients Switching from Analog to Human Insulin
01/29/2019
Results published in JAMA show that patients with type 2 diabetes enrolled in a Medicare Part D plan successfully switched to human insulin from analog, saved on costs and maintained glycemic levels.  
Results published in JAMA show that patients with type 2 diabetes enrolled in a Medicare Part D plan successfully switched to human insulin from analog, saved on costs and maintained glycemic levels.  
Results published in JAMA show...
01/29/2019
First Report Managed Care
Newsfeed
Exclusive-CVS to Cover Migraine Drugs from Teva, Lilly; Excludes AMGEN
01/25/2019
One of the top U.S. managers of pharmacy benefits, CVS, added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to its list of covered drugs
One of the top U.S. managers of pharmacy benefits, CVS, added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to its list of covered drugs
One of the top U.S. managers of...
01/25/2019
First Report Managed Care
Newsfeed
Bristol-Myers Withdraws Approval Application for Lung Cancer Treatment
01/24/2019
The pharmaceutical company withdrew an application that sought approval for a combination of its drugs to treat lung cancer.
The pharmaceutical company withdrew an application that sought approval for a combination of its drugs to treat lung cancer.
The pharmaceutical company...
01/24/2019
First Report Managed Care
Newsfeed
Hospitals Forced to Adjust Staffing and Budgets Due to Rising Drug Prices
01/23/2019
Increased costs for medication combined with frequent drug shortages are compromising patient care and hospital infrastructure.
Increased costs for medication combined with frequent drug shortages are compromising patient care and hospital infrastructure.
Increased costs for medication...
01/23/2019
First Report Managed Care
Newsfeed
US Cost of Insulin Nearly Doubled in Five-Year Period
01/22/2019
A study shows insulin costs per patient with type 1 diabetes have almost doubled from 2012 to 2016, adding turmoil to the fight against rising drug prices.
A study shows insulin costs per patient with type 1 diabetes have almost doubled from 2012 to 2016, adding turmoil to the fight against rising drug prices.
A study shows insulin costs per...
01/22/2019
First Report Managed Care
Newsfeed
Medicaid Expansion Didn`t Improve Hospital Care for Low-Income MI Patients
01/21/2019
According to a study published online in JAMA Cardiology, Medicaid expansion has led to declines in uninsured acute myocardial infarction hospitalizations, but in-hospital care quality has remained unchanged. 
According to a study published online in JAMA Cardiology, Medicaid expansion has led to declines in uninsured acute myocardial infarction hospitalizations, but in-hospital care quality has remained unchanged. 
According to a study published...
01/21/2019
First Report Managed Care
Newsfeed
Are Generic Drugs for Diabetes and Other Diseases Out of Reach?
01/18/2019
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
Patients are often forced into...
01/18/2019
First Report Managed Care
Newsfeed
Specialty Psoriasis Drugs Among Costliest to California Insurers
01/17/2019
Although specialty drugs accounted for just 3% of prescriptions in California, they were responsible for more than half the prescription drug spending by nine insurers in the state in 2017, according to a recent report.
Although specialty drugs accounted for just 3% of prescriptions in California, they were responsible for more than half the prescription drug spending by nine insurers in the state in 2017, according to a recent report.
Although specialty drugs...
01/17/2019
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 1

Current Issue

March 2024
Volume 21
Issue 1
Current Issue
Issue Archive

Advertisement

What's Trending?

Cover Story
Navigating Work With PBMs: Negotiations, Misalignments, and Drug Costs
12/07/2023
Mary Beth Nierengarten
Ignoring the appropriate use of drugs is equally harmful when negotiating with PBMs, as it can and does result in the wrong drugs getting on a formulary with the obvious downstream effect on patient care, costs, and outcomes.
Ignoring the appropriate use of drugs is equally harmful when negotiating with PBMs, as it can and does result in the wrong drugs getting on a formulary with the obvious downstream effect on patient care, costs, and outcomes.
Ignoring the appropriate use of...
12/07/2023
First Report Managed Care
News
CMS Issues Rules on Loss Ratios for Medicare Plans
02/19/2013
02/19/2013
First Report Managed Care
News
Therapy Benefits People With Type 2 Asthma Regardless of Inhaled Corticosteroid Dose
08/01/2023
Jolynn Tumolo
New findings indicate a biologic therapy was efficacious for up to 3 years in patients with uncontrolled, moderate-to-severe asthma.
New findings indicate a biologic therapy was efficacious for up to 3 years in patients with uncontrolled, moderate-to-severe asthma.
New findings indicate a biologic...
08/01/2023
First Report Managed Care
News
Long-term Systemic Treatment for Atopic Dermatitis Does Not Raise Infection Risk
11/22/2022
Jolynn Tumolo
A 4-year study revealed the effects of long-term, continuous dupilumab treatment in patients with moderate-to-severe atopic dermatitis.
A 4-year study revealed the effects of long-term, continuous dupilumab treatment in patients with moderate-to-severe atopic dermatitis.
A 4-year study revealed the...
11/22/2022
First Report Managed Care
News
Mental Disorders Top the List of US Spending by Health Conditions
06/01/2016
When estimating what the United States spends annually for medical conditions for the entire US population, mental disorders top the list, with an annual spending of $201 billion in 2013.
When estimating what the United States spends annually for medical conditions for the entire US population, mental disorders top the list, with an annual spending of $201 billion in 2013.
When estimating what the United...
06/01/2016
First Report Managed Care

Video Insights

Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care
kevin cowart md
Videos
Costs and Benefits: How a New Cholesterol-Lowering Drug Compares to Others
10/24/2023

Featuring Kevin Cowart, PharmD, MPH, BCACP, CDCES

Featuring Kevin Cowart, PharmD, MPH, ...
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant...
10/24/2023
First Report Managed Care
John Hennessy Headshot
Videos
Biosimilars, Explained
10/24/2023

Featuring John Hennessey, MBA

Featuring John Hennessey, MBA
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey,...
10/24/2023
First Report Managed Care
Videos
AVAHO 2023: Andrew Brunner, MD, Discusses Updates in MDS
10/20/2023

Featuring Andrew Brunner, MD

Featuring Andrew Brunner, MD
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner...
10/20/2023
First Report Managed Care
Dr Kesty Headshot
Videos
A Dermatologist's Perspective on Demodex Blepharitis: Causes, Symptoms, and Treatment Options
10/19/2023

Featuring Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser

Featuring Katarina Kesty, MD, MBA, FA...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD,...
10/19/2023
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement